Healthcare provider profile · identity verified

Diana Lee Collins

Nurse Practitioner · LAKE CITY, SC · NPI 1033534151

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	131
Amlodipine Besylate	Amlodipine Besylate	324	93
Pantoprazole Sodium	Pantoprazole Sodium	238	67
Gabapentin	Gabapentin	153	42
Levothyroxine Sodium	Levothyroxine Sodium	153	40
Metformin Hcl	Metformin Hcl	146	37
Alprazolam	Alprazolam	141	24
Diclofenac Sodium	Diclofenac Sodium	132	38
Losartan Potassium	Losartan Potassium	128	37
Hydrochlorothiazide	Hydrochlorothiazide	119	35
Lisinopril	Lisinopril	118	29
Pregabalin	Pregabalin	115	34
Potassium Chloride	Potassium Chloride	112	30
Tramadol Hcl	Tramadol Hcl	103	18
Tamsulosin Hcl	Tamsulosin Hcl	100	23
Jardiance	Empagliflozin	98	18
Metoprolol Succinate	Metoprolol Succinate	98	26
Omeprazole	Omeprazole	97	26
Ezetimibe	Ezetimibe	94	25
Metoprolol Tartrate	Metoprolol Tartrate	91	24
Pravastatin Sodium	Pravastatin Sodium	91	23
Fluticasone Propionate	Fluticasone Propionate	84	31
Furosemide	Furosemide	83	19
Tizanidine Hcl	Tizanidine Hcl	83	27
Trazodone Hcl	Trazodone Hcl	76	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	20
Rosuvastatin Calcium	Rosuvastatin Calcium	71	18
Famotidine	Famotidine	67	22
Eliquis	Apixaban	66	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	61	21
Allopurinol	Allopurinol	61	18
Acetaminophen-Codeine	Acetaminophen With Codeine	60	16
Montelukast Sodium	Montelukast Sodium	60	19
Ibuprofen	Ibuprofen	58	15
Fluoxetine Hcl	Fluoxetine Hcl	57	15
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Meloxicam	Meloxicam	56	15
Prednisone	Prednisone	55	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	suppressed
Hydralazine Hcl	Hydralazine Hcl	50	13
Carvedilol	Carvedilol	49	16
Clopidogrel	Clopidogrel Bisulfate	49	15
Ozempic	Semaglutide	48	suppressed
Fluconazole	Fluconazole	45	21
Lorazepam	Lorazepam	45	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	14
Valsartan	Valsartan	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	12
Hydroxyzine Hcl	Hydroxyzine Hcl	42	suppressed
Nebivolol Hcl	Nebivolol Hcl	42	suppressed
Linzess	Linaclotide	40	14
Mounjaro	Tirzepatide	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Colchicine	Colchicine	34	11
Meclizine Hcl	Meclizine Hcl	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Ketoconazole	Ketoconazole	33	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	20
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Klor-Con M20	Potassium Chloride	29	12
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	11
Triamcinolone Acetonide	Triamcinolone Acetonide	26	12
Ibu	Ibuprofen	25	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	25	suppressed
Atenolol	Atenolol	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Temazepam	Temazepam	24	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Torsemide	Torsemide	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Baclofen	Baclofen	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Azithromycin	Azithromycin	15	11
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Carbamazepine Er	Carbamazepine	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Estradiol	Estradiol	13	suppressed
Naproxen	Naproxen	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Digoxin	Digoxin	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Finasteride	Finasteride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error